{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T04:05:25Z","timestamp":1649131525043},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00292-021-00979-w","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T10:03:20Z","timestamp":1630490600000},"page":"551-559","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Onkozyt\u00e4re Tumoren der Niere\u00a0\u2013 neue Differenzialdiagnosen"],"prefix":"10.1007","volume":"42","author":[{"given":"I.","family":"Polifka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Moch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"979_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00292-016-0158-8","volume":"37","author":"A Agaimy","year":"2016","unstructured":"Agaimy\u00a0A (2016) Succinate dehydrogenase (SDH)-deficient renal cell carcinoma. Pathologe 37:144\u2013152","journal-title":"Pathologe"},{"key":"979_CR2","series-title":"Genitourinary","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-3-642-04566-0","volume-title":"Diagnostic pathology","author":"M Amin","year":"2016","unstructured":"Amin\u00a0M, Tikoo\u00a0SK (2016) Diagnostic pathology, 2.\u00a0Aufl. Genitourinary, S\u00a0243","edition":"2"},{"key":"979_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/PAS.0b013e31818fbdff","volume":"33","author":"P Argani","year":"2009","unstructured":"Argani\u00a0P, Aulmann\u00a0S, Karanjawala\u00a0Z et\u00a0al (2009) Melanotic Xp11 translocation renal cancers: a\u00a0distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Am J Surg Pathol 33:609\u2013619","journal-title":"Am J Surg Pathol"},{"key":"979_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/path.2932","volume":"225","author":"C Bardella","year":"2011","unstructured":"Bardella\u00a0C, El-Bahrawy\u00a0M, Frizzell\u00a0N et al (2011) Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a\u00a0robust biomarker of mutation status. J\u00a0Pathol 225:4\u201311","journal-title":"J Pathol"},{"key":"979_CR5","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.12659\/AJCR.916651","volume":"20","author":"L Bian","year":"2019","unstructured":"Bian\u00a0L, Duan\u00a0J, Wang\u00a0X et\u00a0al (2019) Sarcomatoid chromophobe renal cell carcinoma: a case report and review of the literature. Am J Case Rep 20:1225\u20131230","journal-title":"Am J Case Rep"},{"key":"979_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00292-016-0151-2","volume":"37","author":"E Bruder","year":"2016","unstructured":"Bruder\u00a0E, Moch\u00a0H (2016) Das Translokationskarzinom. Pathologe 37:159\u2013165","journal-title":"Pathologe"},{"key":"979_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","volume":"38","author":"YB Chen","year":"2014","unstructured":"Chen\u00a0YB, Brannon\u00a0AR, Toubaji\u00a0A et al (2014) Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol 38:627\u2013637","journal-title":"Am J Surg Pathol"},{"key":"979_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","volume":"43","author":"YB Chen","year":"2019","unstructured":"Chen\u00a0YB, Mirsadraei\u00a0L, Jayakumaran\u00a0G et\u00a0al (2019) Somatic mutations of TSC2 or MTOR characterize a\u00a0morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm. Am J Surg Pathol 43:121\u2013131","journal-title":"Am J Surg Pathol"},{"key":"979_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/PAS.0b013e3182496895","volume":"36","author":"JC Cheville","year":"2012","unstructured":"Cheville\u00a0JC, Lohse\u00a0CM, Sukov\u00a0WR et\u00a0al (2012) Chromophobe renal cell carcinoma: the impact of tumor grade on outcome. Am J Surg Pathol 36:851\u2013856","journal-title":"Am J Surg Pathol"},{"key":"979_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","volume":"26","author":"CF Davis","year":"2014","unstructured":"Davis\u00a0CF, Ricketts\u00a0CJ, Wang\u00a0M et\u00a0al (2014) The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell 26:319\u2013330","journal-title":"Cancer Cell"},{"key":"979_CR11","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","volume":"37","author":"B Delahunt","year":"2013","unstructured":"Delahunt\u00a0B, Cheville\u00a0JC, Martignoni\u00a0G et\u00a0al (2013) The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 37:1490\u20131504","journal-title":"Am J Surg Pathol"},{"key":"979_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00761-019-0571-8","volume":"25","author":"F Erlmeier","year":"2019","unstructured":"Erlmeier\u00a0F, Agaimy\u00a0A, Hartmann\u00a0A et\u00a0al (2019) Pathologie und Molekularpathologie des Nierenzellkarzinoms. Onkologe 25:497\u2013511","journal-title":"Onkologe"},{"key":"979_CR13","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","volume":"38","author":"AJ Gill","year":"2014","unstructured":"Gill\u00a0AJ, Hes\u00a0O, Papathomas\u00a0T et al (2014) Succinate dehydrogenase (SDH)-deficient renal carcinoma: a\u00a0morphologically distinct entity: a\u00a0clinicopathologic series of 36 tumors from 27\u00a0patients. Am J Surg Pathol 38:1588\u20131602","journal-title":"Am J Surg Pathol"},{"key":"979_CR14","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1097\/PAS.0b013e318227e7f4","volume":"35","author":"AJ Gill","year":"2011","unstructured":"Gill\u00a0AJ, Pachter\u00a0NS, Chou\u00a0A et\u00a0al (2011) Renal tumors associated with germline SDHB mutation show distinctive morphology. Am J Surg Pathol 35:1578\u20131585","journal-title":"Am J Surg Pathol"},{"key":"979_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00428-020-02927-0","volume":"478","author":"Q Guo","year":"2021","unstructured":"Guo\u00a0Q, Liu\u00a0N, Wang\u00a0F et al (2021) Characterization of a\u00a0distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7\u2011positive) based on a\u00a0tertiary oncology center experience: the new evidence from China. Virchows Arch 478:449\u2013458","journal-title":"Virchows Arch"},{"key":"979_CR16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00428-018-2456-4","volume":"473","author":"H He","year":"2018","unstructured":"He\u00a0H, Trpkov\u00a0K, Martinek\u00a0P et al (2018) \u201cHigh-grade oncocytic renal tumor\u201d: morphologic, immunohistochemical, and molecular genetic study of 14\u00a0cases. Virchows Arch 473:725\u2013738","journal-title":"Virchows Arch"},{"key":"979_CR17","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/modpathol.2013.72","volume":"26","author":"W He","year":"2013","unstructured":"He\u00a0W, Cheville\u00a0JC, Sadow\u00a0PM et\u00a0al (2013) Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a\u00a0series of consecutively resected tumors. Mod Pathol 26:1355\u20131364","journal-title":"Mod Pathol"},{"key":"979_CR18","doi-asserted-by":"publisher","first-page":"906924","DOI":"10.1155\/2012\/906924","volume":"2012","author":"V Kufer","year":"2012","unstructured":"Kufer\u00a0V, Schwab\u00a0SA, B\u00fcttner\u00a0M et al (2012) Incidental monotypic (fat-poor) renal angiomyolipoma diagnosed by core needle biopsy. Case Rep Med 2012:906924","journal-title":"Case Rep Med"},{"key":"979_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10689-011-9428-z","volume":"10","author":"HJ Lehtonen","year":"2011","unstructured":"Lehtonen\u00a0HJ (2011) Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer 10:397\u2013411","journal-title":"Fam Cancer"},{"key":"979_CR20","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/his.13395","volume":"72","author":"Y Li","year":"2018","unstructured":"Li\u00a0Y, Reuter\u00a0VE, Matoso\u00a0A et al (2018) Re-evaluation of 33 \u2018unclassified\u2019 eosinophilic renal cell carcinomas in young patients. Histopathology 72:588\u2013600","journal-title":"Histopathology"},{"key":"979_CR21","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.5858\/2007-131-1290-IAOCRC","volume":"131","author":"L Liu","year":"2007","unstructured":"Liu\u00a0L, Qian\u00a0J, Singh\u00a0H et\u00a0al (2007) Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Arch Pathol Lab Med 131:1290\u20131297","journal-title":"Arch Pathol Lab Med"},{"key":"979_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.5858\/2002-126-0610-OLA","volume":"126","author":"G Martignoni","year":"2002","unstructured":"Martignoni\u00a0G, Pea\u00a0M, Bonetti\u00a0F et al (2002) Oncocytoma-like angiomyolipoma. A clinicopathologic and immunohistochemical study of 2\u00a0cases. Arch Pathol Lab Med 126:610\u2013612","journal-title":"Arch Pathol Lab Med"},{"key":"979_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/00000478-199806000-00003","volume":"22","author":"G Martignoni","year":"1998","unstructured":"Martignoni\u00a0G, Pea\u00a0M, Bonetti\u00a0F et\u00a0al (1998) Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a\u00a0clinicopathologic and genetic study. Am J Surg Pathol 22:663\u2013672","journal-title":"Am J Surg Pathol"},{"key":"979_CR24","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","volume":"31","author":"MJ Merino","year":"2007","unstructured":"Merino\u00a0MJ, Torres-Cabala\u00a0C, Pinto\u00a0P et al (2007) The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 31:1578\u20131585","journal-title":"Am J Surg Pathol"},{"key":"979_CR25","doi-asserted-by":"publisher","first-page":"151448","DOI":"10.1016\/j.anndiagpath.2019.151448","volume":"44","author":"K Michalova","year":"2020","unstructured":"Michalova\u00a0K, Tretiakova\u00a0M, Pivovarcikova\u00a0K et\u00a0al (2020) Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8\u00a0cases with papillary architecture. Ann Diagn Pathol 44:151448","journal-title":"Ann Diagn Pathol"},{"key":"979_CR26","doi-asserted-by":"publisher","first-page":"S350","DOI":"10.21037\/atm.2019.09.77","volume":"7","author":"S Mikami","year":"2019","unstructured":"Mikami\u00a0S, Kuroda\u00a0N, Nagashima\u00a0Y et\u00a0al (2019) Classification of solid renal tumor with oncocytic\/eosinophilic cytoplasm: is hybrid oncocytic\/chromophobe renal tumor a\u00a0subtype of oncocytoma, chromophobe renal cell carcinoma, or a\u00a0distinct tumor entity? Ann Transl Med 7:S350","journal-title":"Ann Transl Med"},{"key":"979_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch\u00a0H, Cubilla\u00a0AL, Humphrey\u00a0PA et\u00a0al (2016) The 2016 WHO classification of tumours of the urinary system and Male genital organs\u2014Part A: renal, penile, and testicular tumours. Eur Urol 70:93\u2013105","journal-title":"Eur Urol"},{"key":"979_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pathol.2020.09.015","volume":"53","author":"H Moch","year":"2021","unstructured":"Moch\u00a0H, Ohashi\u00a0R (2021) Chromophobe renal cell carcinoma: current and controversial issues. Pathology 53:101\u2013108","journal-title":"Pathology"},{"key":"979_CR29","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41379-018-0017-7","volume":"31","author":"M Muller","year":"2018","unstructured":"Muller\u00a0M, Guillaud-Bataille\u00a0M, Salleron\u00a0J et al (2018) Pattern multiplicity and fumarate hydratase (FH)\/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration. Mod Pathol 31:974\u2013983","journal-title":"Mod Pathol"},{"key":"979_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/PAS.0b013e318206f2a9","volume":"35","author":"N Nese","year":"2011","unstructured":"Nese\u00a0N, Martignoni\u00a0G, Fletcher\u00a0CD et al (2011) Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41\u00a0cases: detailed assessment of morphology and risk stratification. Am J Surg Pathol 35:161\u2013176","journal-title":"Am J Surg Pathol"},{"key":"979_CR31","unstructured":"Ohashi R (2021) stains vimentin. https:\/\/www.pathologyoutlines.com\/topic\/stainsvimentin.html. Zugegriffen: 19.\u00a0Mai 2021"},{"key":"979_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020465","author":"R Ohashi","year":"2020","unstructured":"Ohashi\u00a0R, Angori\u00a0S, Batavia\u00a0AA et\u00a0al (2020) Loss of CDKN1A mRNA and protein expression are independent predictors of poor outcome in chromophobe renal cell carcinoma patients. Cancers. https:\/\/doi.org\/10.3390\/cancers12020465","journal-title":"Cancers"},{"key":"979_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00428-019-02710-w","volume":"476","author":"R Ohashi","year":"2020","unstructured":"Ohashi\u00a0R, Martignoni\u00a0G, Hartmann\u00a0A et al (2020) Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a\u00a0novel two-tiered grading scheme. Virchows Arch 476:409\u2013418","journal-title":"Virchows Arch"},{"key":"979_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101492","author":"R Ohashi","year":"2019","unstructured":"Ohashi\u00a0R, Schraml\u00a0P, Angori\u00a0S et\u00a0al (2019) Classic chromophobe renal cell carcinoma incur a\u00a0larger number of chromosomal losses than seen in the eosinophilic subtype. Cancers. https:\/\/doi.org\/10.3390\/cancers11101492","journal-title":"Cancers"},{"key":"979_CR35","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.tranon.2019.05.005","volume":"12","author":"R Ohashi","year":"2019","unstructured":"Ohashi\u00a0R, Schraml\u00a0P, Batavia\u00a0A et\u00a0al (2019) Allele loss and reduced expression of CYCLOPS genes is a\u00a0characteristic feature of chromophobe renal cell carcinoma. Transl Oncol 12:1131\u20131137","journal-title":"Transl Oncol"},{"key":"979_CR36","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/his.13362","volume":"72","author":"CM Perrino","year":"2018","unstructured":"Perrino\u00a0CM, Grignon\u00a0DJ, Williamson\u00a0SR et\u00a0al (2018) Morphological spectrum of renal cell carcinoma, unclassified: an analysis of 136\u00a0cases. Histopathology 72:305\u2013319","journal-title":"Histopathology"},{"key":"979_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00428-010-0898-4","volume":"456","author":"F Petersson","year":"2010","unstructured":"Petersson\u00a0F, Gatalica\u00a0Z, Grossmann\u00a0P et\u00a0al (2010) Sporadic hybrid oncocytic\/chromophobe tumor of the kidney: a\u00a0clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14\u00a0cases. Virchows Arch 456:355\u2013365","journal-title":"Virchows Arch"},{"key":"979_CR38","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1097\/PAS.0000000000000258","volume":"38","author":"VE Reuter","year":"2014","unstructured":"Reuter\u00a0VE, Argani\u00a0P, Zhou\u00a0M et\u00a0al (2014) Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 38:e35\u2013e49","journal-title":"Am J Surg Pathol"},{"key":"979_CR39","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/s41379-019-0304-y","volume":"32","author":"R Ruiz-Cordero","year":"2019","unstructured":"Ruiz-Cordero\u00a0R, Rao\u00a0P, Li\u00a0L et al (2019) Hybrid oncocytic\/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma. Mod Pathol 32:1698\u20131707","journal-title":"Mod Pathol"},{"key":"979_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00120-019-01108-5","volume":"59","author":"NJ Rupp","year":"2020","unstructured":"Rupp\u00a0NJ, Moch\u00a0H (2020) Charakterisierung der unterschiedlichen Entit\u00e4ten beim Nierenzellkarzinom. Urologe 59:135\u2013141","journal-title":"Urologe"},{"key":"979_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010168","author":"F Siadat","year":"2020","unstructured":"Siadat\u00a0F, Trpkov\u00a0K (2020) ESC, ALK, HOT and LOT: three letter acronyms of emerging renal entities knocking on the door of the WHO classification. Cancers. https:\/\/doi.org\/10.3390\/cancers12010168","journal-title":"Cancers"},{"key":"979_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.eururo.2020.03.003","volume":"78","author":"SL Skala","year":"2020","unstructured":"Skala\u00a0SL, Wang\u00a0X, Zhang\u00a0Y et al (2020) Next-generation RNA sequencing-based Biomarker characterization of chromophobe renal cell carcinoma and related oncocytic neoplasms. Eur Urol 78:63\u201374","journal-title":"Eur Urol"},{"key":"979_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/his.13183","volume":"71","author":"SC Smith","year":"2017","unstructured":"Smith\u00a0SC, Sirohi\u00a0D, Ohe\u00a0C et al (2017) A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma. Histopathology 71:42\u201352","journal-title":"Histopathology"},{"key":"979_CR44","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","volume":"37","author":"JR Srigley","year":"2013","unstructured":"Srigley\u00a0JR, Delahunt\u00a0B, Eble\u00a0JN et\u00a0al (2013) The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia. Am J Surg Pathol 37:1469\u20131489","journal-title":"Am J Surg Pathol"},{"key":"979_CR45","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R","volume":"80","author":"S St\u00f6rkel","year":"1997","unstructured":"St\u00f6rkel\u00a0S, Eble\u00a0JN, Adlakha\u00a0K et\u00a0al (1997) Classification of renal cell carcinoma. Cancer 80:987\u2013989","journal-title":"Cancer"},{"key":"979_CR46","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1097\/00000478-200009000-00008","volume":"24","author":"SK Tickoo","year":"2000","unstructured":"Tickoo\u00a0SK, Lee\u00a0MW, Eble\u00a0JN et\u00a0al (2000) Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol 24:1247\u20131256","journal-title":"Am J Surg Pathol"},{"key":"979_CR47","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/PAS.0000000000001457","volume":"44","author":"M Tjota","year":"2020","unstructured":"Tjota\u00a0M, Chen\u00a0H, Parilla\u00a0M et\u00a0al (2020) Eosinophilic renal cell tumors with a\u00a0TSC and MTOR gene mutations are morphologically and Immunohistochemically heterogenous: clinicopathologic and molecular study. Am J Surg Pathol 44:943\u2013954","journal-title":"Am J Surg Pathol"},{"key":"979_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2020.12.006","author":"MY Tjota","year":"2020","unstructured":"Tjota\u00a0MY, Wanjari\u00a0P, Segal\u00a0J et\u00a0al (2020) TSC\/MTOR mutated eosinophilic renal tumors are a\u00a0distinct entity that are CK7+\/CK20\u2212\/vimentin\u2212: a\u00a0validation study. Hum Pathol. https:\/\/doi.org\/10.1016\/j.humpath.2020.12.006","journal-title":"Hum Pathol"},{"key":"979_CR49","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","volume":"41","author":"K Trpkov","year":"2017","unstructured":"Trpkov\u00a0K, Abou-Ouf\u00a0H, Hes\u00a0O et al (2017) Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a\u00a0distinct entity. Am J Surg Pathol 41:1299\u20131308","journal-title":"Am J Surg Pathol"},{"key":"979_CR50","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/his.13876","volume":"75","author":"K Trpkov","year":"2019","unstructured":"Trpkov\u00a0K, Bonert\u00a0M, Gao\u00a0Y et al (2019) High-grade oncocytic tumour (HOT) of kidney in a\u00a0patient with tuberous sclerosis complex. Histopathology 75:440\u2013442","journal-title":"Histopathology"},{"key":"979_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00779-w","author":"K Trpkov","year":"2021","unstructured":"Trpkov\u00a0K, Hes\u00a0O, Williamson\u00a0SR et\u00a0al (2021) New developments in existing WHO entities and evolving molecular concepts: the Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. https:\/\/doi.org\/10.1038\/s41379-021-00779-w","journal-title":"Mod Pathol"},{"key":"979_CR52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/his.13865","volume":"75","author":"K Trpkov","year":"2019","unstructured":"Trpkov\u00a0K, Williamson\u00a0SR, Gao\u00a0Y et al (2019) Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7\u2011positive): a\u00a0distinct entity? Histopathology 75:174\u2013184","journal-title":"Histopathology"},{"key":"979_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00737-6","author":"K Trpkov","year":"2021","unstructured":"Trpkov\u00a0K, Williamson\u00a0SR, Gill\u00a0AJ et\u00a0al (2021) Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. https:\/\/doi.org\/10.1038\/s41379-021-00737-6","journal-title":"Mod Pathol"},{"key":"979_CR54","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1365-2559.2010.03726.x","volume":"57","author":"K Trpkov","year":"2010","unstructured":"Trpkov\u00a0K, Yilmaz\u00a0A, Uzer\u00a0D et\u00a0al (2010) Renal oncocytoma revisited: a\u00a0clinicopathological study of 109\u00a0cases with emphasis on problematic diagnostic features. Histopathology 57:893\u2013906","journal-title":"Histopathology"},{"key":"979_CR55","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1464-410X.2011.10690.x","volume":"110","author":"A Volpe","year":"2012","unstructured":"Volpe\u00a0A, Novara\u00a0G, Antonelli\u00a0A et\u00a0al (2012) Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a\u00a0large multicentre series. BJU Int 110:76\u201383","journal-title":"BJU Int"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-021-00979-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-021-00979-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-021-00979-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T02:21:58Z","timestamp":1635214918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-021-00979-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["979"],"URL":"https:\/\/doi.org\/10.1007\/s00292-021-00979-w","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"14 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0Moch ist \u201eStanding Member\u201c des Editorial Boards der Blue Book-Serie \u201eWHO Classification of Tumours\u201c. I.\u00a0Polifka und R.\u00a0Ohashi geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}